Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral Presentations - Physicians/Scientists/Pharmacists

Synthesis and evaluation of the dopamine D2 and D3 receptor agonists, (R,S)-18F-5-OH-FPPAT and (R,S)-18F-7-OH-FHXPAT

Portia Trinidad, Kathy Kim, Rama Pichika, Balu Easwaramoorthy, Daphne Collins and Jogeshwar Mukherjee
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 28P;
Portia Trinidad
1Psychiatry & Human Behavior, University of California Irvine, Irvine, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathy Kim
1Psychiatry & Human Behavior, University of California Irvine, Irvine, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rama Pichika
1Psychiatry & Human Behavior, University of California Irvine, Irvine, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Balu Easwaramoorthy
1Psychiatry & Human Behavior, University of California Irvine, Irvine, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daphne Collins
1Psychiatry & Human Behavior, University of California Irvine, Irvine, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jogeshwar Mukherjee
1Psychiatry & Human Behavior, University of California Irvine, Irvine, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

80

Objectives: Dopamine D2 and D3 receptors have been associated with a number of neurological and psychiatric disorders. Development of agonist-based imaging methodologies of this receptor is important for studies of normal and abnormal brain function, and dopamine competition studies. Our goals are: (1) Synthesize and evaluate 18F-7-OH-FHXPAT as a potential tracer for D3 receptors; (2) Improve and automate reported 3-step radiosynthesis of 18F-5-OH-FPPAT to 2-steps (Shi et al., NMB, 2004).

Methods: Two precursor molecules, 2-(N-propyl-N-5’-bromopentyl)amino-5-tetrahydroxypyranyltetralin (for 18F-5-OH-FPPAT) and 2-(N-propyl-N-5’-bromohexyl)amino-7-tetrahydroxypyranyltetralin (for 18F-7-OH-FHXPAT) were prepared using the respective tetralones. Radiolabeling of the bromo-precursors were carried out using 18F-fluoride, Kryptofix/K2CO3 in acetonitrile at 95oC for 30 min. Product mixture was purified on RP-HPLC (CH3CN:H2O 0.25%Et3N, 68%:32%; flow rate 2.5 ml/min). Brain slices (10μm thick) from male Sprague-Dawley rats were used for in vitro binding studies. Slides were preincubated at RT for 10 min in Tris-HCl buffer (pH 7.4). Slices were incubated with 5-6 μCi/cc of 18F-5-OH-FPPAT or 18F-7-OH-FHXPAT at 37oC for 1 hr. For competition studies, brain slices were incubated with dopamine. Nonspecific binding was measured using 10μM sulpiride. Slides were rinsed twice for 2 min in ice-cold buffer, dipped in ice water, blown dry and laid out for autoradiography. Slides with tissue samples were exposed to a multipurpose storage phosphor screen for 24 hours, developed, and quantified. Specific binding to D2 and D3 receptors in striatum (St), cortex (Ctx), and cerebellum (Cer) were measured.

Results: Radiosynthesis of the THP-protected bromo-precursors proceeded in high radiochemical yields (approx.30%) and the THP was deprotected under mild acidic conditions. This procedure avoided a previously reported hydride reduction step. The products were obtained in specific activities of >2000 Ci/mmol. Binding characteristics of the 5-hydroxy and 7-hydroxy derivatives were distinctly different. While 18F-5-OH-FPPAT bound predominantly to the striata an area rich in D2 receptors (St/Cer=17), binding of 18F-7-OH-FHXPAT was more wide-spread. Binding was seen in the striata (St/Cer=2) which was sensitive to increasing dopamine. Regions in the cerebellum (possibly D3 sites) were more evident with 18F-7-OH-FHXPAT. A greater degree of binding in the cortex and hippocampus was seen with 18F-7-OH-FHXPAT compared to 18F-5-OH-FPPAT.

Conclusions: A two step radiosynthesis has been successfully carried out for previously described 18F-5-OH-FPPAT as well as a new radiotracer, 18F-7-OH-FHXPAT. Further investigation on the nature of their binding (D2 versus D3) is underway.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and evaluation of the dopamine D2 and D3 receptor agonists, (R,S)-18F-5-OH-FPPAT and (R,S)-18F-7-OH-FHXPAT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and evaluation of the dopamine D2 and D3 receptor agonists, (R,S)-18F-5-OH-FPPAT and (R,S)-18F-7-OH-FHXPAT
Portia Trinidad, Kathy Kim, Rama Pichika, Balu Easwaramoorthy, Daphne Collins, Jogeshwar Mukherjee
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 28P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and evaluation of the dopamine D2 and D3 receptor agonists, (R,S)-18F-5-OH-FPPAT and (R,S)-18F-7-OH-FHXPAT
Portia Trinidad, Kathy Kim, Rama Pichika, Balu Easwaramoorthy, Daphne Collins, Jogeshwar Mukherjee
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 28P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral Presentations - Physicians/Scientists/Pharmacists

  • Role of FDG-PET/CT in the management of patients with CUP syndrome (cancer of unknown primary site) and extra cervical biopsy proven metastases
  • Diagnosis ability of dual-phase F-18-fluoro-2-deoxy-D-glucose SPECT/PET for distinguishing the benign and malignant lesions
  • 123I-Ioflupane striatal binding in PARK8 and PARK2-linked Parkinson’s disease: A SPECT comparative study
Show more Oral Presentations - Physicians/Scientists/Pharmacists

Radiopharmaceutical Chemistry Track

  • Preparation of high specific activity Fluorine-18 nanoparticles using click chemistry
  • Comparison of polymeric conjugates of mono- and bi-cyclic RGD peptide for αvβ3 integrin targeting
  • Adsorption of metal radionuclides on plastics and the effect on absorbed dose estimates using phantoms
Show more Radiopharmaceutical Chemistry Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire